<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="antioxidants-09-00573-t004" orientation="portrait" position="float">
 <object-id pub-id-type="pii">antioxidants-09-00573-t004_Table 4</object-id>
 <label>Table 4</label>
 <caption>
  <p>Effect of nuclear factor kappa B (NFκB) and AMP-activated protein kinase (AMPK) inhibition on intracellular ROS levels of cerebral endothelial cells during hyperglycemic condition.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Conditions</th>
    <th colspan="3" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Intracellular ROS Levels (% of Control)</th>
   </tr>
   <tr>
    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </th>
    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vehicle</th>
    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NFκB Inhibition</th>
    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AMPK Inhibition</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="middle" rowspan="1" colspan="1">Normoglycemic condition</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">100 ± 2.12</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">80.38 ± 2.92 *</td>
    <td align="left" valign="middle" rowspan="1" colspan="1">137.89 ± 3.19 ***</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hyperglycemic condition</td>
    <td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">127.75 ± 2.66 ***</td>
    <td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">80.28 ± 3.21 ###</td>
    <td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">142.16 ± 2.88 ##</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Cells were preconditioned with NFκB and AMPK inhibitors (10 µM), for 1 h before the exposition to DCFH-DA probe for 45 min. Subsequently, the cells were co-exposed to the inhibitors (10 µM) and 5.5 mM or 33 mM of glucose to mimic normoglycemic and hyperglycemic conditions, respectively. Intracellular ROS levels were measured by DCFH-DA assay. The data are means ± SEM of three independent experiments. *: 
    <italic>p</italic> &lt; 0.05 and ***: 
    <italic>p</italic> &lt; 0.005 as compared to normoglycemic condition. ##: 
    <italic>p</italic> &lt; 0.01 and ###: 
    <italic>p</italic> &lt; 0.005 as compared to hyperglycemic condition.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
